III. Chemokines and other mediators, 8. Chemokines and their receptors in cell-mediated immune responses in the lung

Microscopy Research and Technique

Volumn 53, Issue 4, 2001, Pages 298-306

  Matsukawa, Akihiro ^a   Lukacs, Nicholas W ^a   Hogaboam, Cory M ^a   Chensue, Stephen W ^b   Kunkel, Steven L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Cell cell communication; Chemotactic cytokines; Delayed hypersensitivity; Th1 Th2

Indexed keywords

BIOLOGICAL ORGANS; CYTOLOGY; IMMUNE SYSTEM; PEPTIDES; TISSUE;

CELL-CELL COMMUNICATIONS; CELL-MEDIATED IMMUNE; CHEMOKINE RECEPTORS; CHEMOKINES; CHEMOTACTIC CYTOKINE; CYTOKINES; DELAYED HYPERSENSITIVITY; IMMUNE RESPONSE; LYMPHOID TISSUE; TH1/TH2;

T-CELLS;

CHEMOKINE; CHEMOKINE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR IMMUNITY; DENDRITIC CELL; HELPER CELL; IMMUNE RESPONSE; LUNG PARENCHYMA; LYMPHOID TISSUE; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; MOUSE; MULTIGENE FAMILY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR BINDING;

EID: 0035873241     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1096     Document Type: Article

References (95)

1. Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, Foster J, Xu Y, Nooyen P, McClanahan T, Bacon KB, Figdor CG. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713-717.
2. Agostini C, Perin A, Semenzato G. 1998. Cell apoptosis and granulomatous lung diseases. Curr Opin Pulm Med 4:261-266.
3. Allavena P, Luini W, Bonecchi R, D'Amico G, Bianchi G, Longoni D, Vecchi A, Mantovani A, Sozzani S. 1999. Chemokines and chemokine receptors in the regulation of dendritic cell trafficking. Chem Immunol 72:69-85.
4. Ando M, Suga M, Kohrogi H. 1999. A new look at hypersensitivity pneumonitis. Curr Opin Pulm Med 5:299-304.
5. Annunziato F, Cosmi L, Galli G, Beltrame C, Romagnani P, Manetti R, Romagnani S, Maggi E. 1999. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J Leukoc Biol 65:691-699.
6. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG. 1999. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J Exp Med 190:1123-1134.
7. Bacon KB, Premack BA, Gardner P, Schall TJ. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269:1727-1730.
8. Bacon KB, Szabo MC, Yssel H, Bolen JB, Schall TJ. 1996. RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells. J Exp Med 184:873-882.
9. Baggiolini M. 1998. Chemokines and leukocyte traffic. Nature 392: 565-568.
10. Baggiolini M, Dewald B, Moser B. 1997. Human chemokines: an update. Annu Rev Immunol 15:675-705.
11. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129-134.
12. Bonecchi R, Polentarutti N, Luini W, Borsatti A, Bernasconi S, Locati M, Power C, Proudfoot A, Wells TN, Mackay C, Mantovani A, Sozzani S. 1999. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. J Immunol 162:474-479.
13. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100:2552-2561.
14. Chensue SW, Terebuh PD, Warmington KS, Hershey SD, Evanoff HL, Kunkel SL, Higashi GI. 1992. Role of IL-4 and IFN-gamma in Schistosoma mansoni egg-induced hypersensitivity granuloma formation. Orchestration, relative contribution, and relationship to macrophage function. J Immunol 148:900-906.
15. Chensue SW, Warmington K, Ruth J, Lincoln P, Kuo MC, Kunkel SL. 1994a. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am J Pathol 145:1105-1113.
16. Chensue SW, Warmington KS, Ruth J, Lincoln PM, Kunkel SL. 1994b. Cross-regulatory role of interferon-gamma (IFN-gamma), IL-4 and IL-10 in schistosome egg granuloma formation: in vivo regulation of Th activity and inflammation. Clin Exp Immunol 98:395-400.
17. Chensue SW, Ruth JH, Warmington K, Lincoln P, Kunkel SL. 1995a. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J Immunol 155:3546-3551.
18. Chensue SW, Warmington KS, Lukacs NW, Lincoln PM, Burdick MD, Strieter RM, Kunkel SL. 1995b. Monocyte chemotactic protein expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation. Am J Pathol 146:130-138.
19. Chensue SW, Warmington KS, Ruth JH, Lincoln P, Kunkel SL. 1995c. Cytokine function during mycobacterial and shicstosomal antigen-induced pulmonary granuloma formation. Local and regional participation of IFN-gamma, IL-10, and TNF. J Immunol 154:5969-5976.
20. Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P, Kunkel SL. 1996. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol 157:4602-4608.
21. Chensue SW, Warmington K, Ruth JH, Kunkel SL. 1997a. Effect of slow release IL-12 and IL-10 on inflammation,local macrophage function and the regional lymphoid response during mycobacterial (Th1) and schistosomal (Th2) antigen-elicited pulmonary granuloma formation. Inflamm Res 46:86-92.
22. Chensue SW, Warmington KS, Ruth JH, Lukacs N, Kunkel SL. 1997b. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. J Immunol 159: 3565-3573.
23. Chensue SW, Warmington KS, Allenspach EJ, Lu B, Gerard C, Kunkel SL, Lukacs NW. 1999. Differential expression and cross-regulatory function of RANTES during mycobacterioal (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol 163:165-173.
24. Colantonio L, Iellem A, Clissi B, Pardi R, Rogge L, Sinigaglia F, D'Ambrosio D. 1999. Upregulation of integrin alpha6/beta1 and chemokine receptor CCR1 by interleukin-12 promotes the migration of human type 1 helper T cells. Blood 94:2981-2989.
25. Condos R, Rom WN, Weiden M. 2000. Lung-specific immune response in tuberculosis. Int J Tuberc Lung Dis 4:811-17.
26. Constant SL, Bottomly K. 1997. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 15: 297-322.
27. Cyster JG. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286:2098-2102.
28. D'Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A, Sinigaglia F. 1998. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 161:5111-5115.
29. D'Ambrosio D, Iellem A, Colantonio L, Clissi B, Pardi R, Sinigaglia F. 2000. Localization of Th-cell subsets in inflammation: differential thresholds for extravasation of Th1 and Th2 cells. Immunol Today 21:183-186.
30. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Ait-Yahia S, Briere F, Zlotnik A, Lebecque S, Caux C. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188:373-386.
31. Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN. 2000. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 164:2585-2591.
32. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-1047.
33. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33.
34. Galli G, Chantry D, Annunziato F, Romagnani P, Cosmi L, Lazzeri E, Manetti R, Maggi E, Gray PW, Romagnani S. 2000. Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. Eur J Immunol 30:204-210.
35. Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon-Chung J, Murphy PM. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185:1959-1968.
36. Gharaee-Kermani M, Denholm EM, Phan SH. 1996. Costimulation of fibroblast collagen and transforming growth factor betal gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 271:17779-17784.
37. Guan P, Burghes AH, Cunningham A, Lira P, Brissette WH, Neote K, McColl SR. 1999. Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/ SCYA18. Genomics 56:296-302.
38. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, Williams LT, Nakano H. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189:451-460.
39. Henderson GS, Conary JT, Summar M, McCurley TL, Colley DG. 1991. In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. I. IL-4 mRNA, not IL-2 mRNA, is abundant in the granulomatous livers, mesenteric lymph nodes, and spleens of infected mice. J Immunol 147:992-997.
40. Henderson GS, Lu X, McCurley TL, Colley DG. 1992. In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. II. Quantification of IL-4 mRNA, IFN-gamma mRNA, and IL-2 mRNA levels in the granulomatous livers, mesenteric lymph nodes, and spleens during the course of modulation. J Immunol 148:2261-2269.
41. Hogaboam CM, Bone-Larson CL, Lipinski S, Lukacs NW, Chensue SW, Strieter RM, Kunkel SL. 1999a. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1-and Th2-type pulmonary granuloma models. J Immunol 163:2193-2201.
42. Hogaboam CM, Bone-Larson CL, Steinhauser ML, Lukacs NW, Colletti LM, Simpson KJ, Strieter RM, Kunkel SL. 1999b. Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines. Faseb J 13:1565-1574.
43. Hogaboam CM, Chensue SW, Kunkel SL. 1999c. The role of CC chemokines in Th1-and Th2-type pulmonary inflammation models. In: Hebert CA, editor. Chemokines in disease. Totowa, NJ: Humana Press. p 139-149.
44. Hogaboam CM, Lukacs NW, Chensue SW, Strieter RM, Kunkel SL. 1998. Monocyte chemoattractant protein-1 synthesis by murine lung fibroblasts modulates CD4+ T cell activation. J Immunol 160:4606-4614.
45. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, Yoshie O. 1999. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11:81-88.
46. Johnston B, Burns AR, Suematsu M, Issekutz TB, Woodman RC, Kubes P. 1999. Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J Clin Invest 103:1269-1276.
47. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WAS, Hurst SD, Barrett TA. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158:4129-4136.
48. Karpus WJ, Kennedy KJ, Kunkel SL, Lukacs NW. 1998. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J Exp Med 187:733-741.
49. Kay AB. 1998. Role of T cells in asthma. Chem Immunol 71:178-191.
50. Keane MP, Strieter RM. 1999. The role of CXC chemokines in the regulation of angiogenesis. Chem Immunol 72:86-101.
51. Kon OM, Kay AB. 1999. T cells and chronic asthma. Int Arch Allergy Immunol 118:133-135.
52. Kunkel SL, Lukacs NW, Strieter RM, Chensue SW. 1996. Th1 and Th2 responses regulate experimental lung granuloma development. Sarcoid Vasc Diffuse Lung Dis 13:120-128.
53. Kunkel SL, Lukacs NW, Strieter RM, Chensue SW. 1998. Animal models of granulomatous inflammation. Semin Respir Infect 13: 221-228.
54. Le Gros G, Erb K, Harris N, Holloway J, McCoy K, Ronchese F. 1998. Immunoregulatory networks in asthma. Clin Exp Allergy 28:92-96 [discussion 117-118].
55. Lloyd CM, Delaney T, Nguyen T, Tian J, Martinez AC, Coyle AJ, Gutierrez-Ramos JC. 2000. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 191:265-274.
56. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601-608.
57. Ludewig B, Odermatt B, Ochsenbein AF, Zinkernagel RM, Hengartner H. 1999. Role of dendritic cells in the induction and maintenance of autoimmune diseases. Immunol Rev 169:45-54.
58. Lukacs NW, Addison CL, Gauldie J, Graham F, Simpson K, Strieter RM, Warmington K, Chensue SW, Kunkel SL. 1997a. Transgene-induced production of IL-4 alters the development and collagen expression of T helper cell 1-type pulmonary granulomas. J Immunol 158:4478-4484.
59. Lukacs NW, Chensue SW, Karpus WJ, Lincoln P, Reefer C, Strieter RM, Kunkel SL. 1997b. C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am J Pathol 150:1861-1868.
60. Lukacs NW, Hogaboam C, Campbell E, Kunkel SL. 1999. Chemokines: function, regulation and alteration of inflammatory responses. Chem Immunol 72:102-120.
61. Mahalingam S, Karupiah G. 1999. Chemokines and chemokine receptors in infectious diseases. Immunol Cell Biol 77:469-475.
62. Mantovani A, Allavena P, Vecchi A, Sozzani S. 1998. Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses. Int J Clin Lab Res 28:77-82.
63. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL. 2000a. Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis. Exp Mol Pathol 68:77-84.
64. Matsukawa A, Lukacs NW, Standiford TJ, Chensue SW, Kunkel SL. 2000b. Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo. J Immunol 164:1699-1704.
65. Moller DR. 1999. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoid Vasc Diffuse Lung Dis 16:24-31.
66. Moser B. 1998. Human chemokines: role in lymphocyte trafficking. Sci Prog 81:299-313.
67. Murphy PM. 1997. Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol 34:311-318.
68. Ngo VN, Tang HL, Cyster JG. 1998. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med 188:181-191.
69. Penton-Rol G, Polentarutti N, Luini W, Borsatti A, Mancinelli R, Sica A, Sozzani S, Mantovani A. 1998. Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. J Immunol 160:3869-3873.
70. +-CXC chemokines in wound healing and melanoma biology. In: Hebert CA, editor. Chemokines in disease. Totowa, NJ: Humana Pres Inc. p 191-214.
71. Roitt I, Brostoff J, Male D. 1998. Immunology. London: Mosby.
72. Romagnani S. 1997. The Th1/Th2 paradigm. Immunol Today 18:263-266.
73. Rossi DL, Hurst SD, Xu Y, Wang W, Menon S, Coffman RL, Zlotnik A. 1999. Lungkine, a novel CXC chemokine, specifically expressed by lung bronchoepithelial cells. J Immunol 162:5490-5497.
74. Rothenberg ME. 2000. Chemokines in allergic disease. New York: Marcel Dekker.
75. Rothenberg ME, Zimmermann N, Mishra A, Brandt E, Birkenberger LA, Hogan SP, Foster PS. 1999. Chemokines and chemokine receptors: their role in allergic airway disease. J Clin Immunol 19:250-265.
76. Roussos C. 1995. The Thorax. Lung biology in health and disease, 2nd ed. New York: Marcel Dekker.
77. Ruth JH, Lukacs NW, Warmington KS, Polak TJ, Burdick M, Kunkel SL, Strieter RM, Chensue SW. 1998. Expression and participation of eotaxin during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation. J Immunol 161:4276-4282.
78. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ. 1995. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 155:4838-4843.
79. Saeki H, Moore AM, Brown MJ, Hwang ST. 1999. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162:2472-2475.
80. Sallusto F, Lanzavecchia A, Mackay CR. 1998a. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19:568-574.
81. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. 1998b. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875-883.
82. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S, Forster R, Lipp M, Lanzavecchia A. 1999. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 29:2037-2045.
83. Soto H, Wang W, Strieter RM, Copeland NG, Gilbert DJ, Jenkins NA, Hedrick J, Zlotnik A. 1998. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc Natl Acad Sci USA 95:8205-8210.
84. Syrbe U, Siveke J, Hamann A. 1999. Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression? Springer Semin Immunopathol 21:263-285.
85. Taub DD, Ortaldo JR, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. 1996a. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol 59:81-89.
86. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. 1996b. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol 156:2095-2103.
87. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, Imai T, Yoshie O, Irimura T, Mizutani H, Matsushima K. 1999. Overproduction of Th2-specific chemokines in NC/ Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104:1097-1105.
88. Walker LS, Gulbranson-Judge A, Flynn S, Brocker T, Raykundalia C, Goodall M, Forster R, Lipp M, Lane P. 1999. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J Exp Med 190:1115-1122.
89. Warmington KS, Boring L, Ruth JH, Sonstein J, Hogaboam CM, Curtis JL, Kunkel SL, Charo IR, Chensue SW. 1999. Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses. Am J Pathol 154:1407-1416.
90. Yoneyama H, Harada A, Imai T, Baba M, Yoshie O, Zhang Y, Higashi H, Murai M, Asakura H, Matsushima K. 1998. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J Clin Invest 102:1933-1941.
91. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233-9237.
92. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. 1989. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 244:487-493.
93. Zisman DA, Kunkel SL, Strieter RM, Tsai WC, Bucknell K, Wilkowski J, Standiford TJ. 1997. MCP-1 protects mice in lethal endotoxemia. J Clin Invest 99:2832-2836.
94. Zlotnik A, Morales J, Hedrick JA. 1999. Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 19:1-47.
95. Zlotnik A, Yoshie O. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121-127.